White Pine Capital’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$382K Sell
1,432
-111
-7% -$30.1K 0.11% 184
2025
Q4
$387K Buy
1,543
+3
+0.2% +$797 0.11% 178
2025
Q3
$442K Buy
1,540
+35
+2% +$9.38K 0.13% 173
2025
Q2
$395K Buy
1,505
+30
+2% +$7.3K 0.13% 171
2025
Q1
$343K Hold
1,475
0.12% 173
2024
Q4
$338K Buy
1,475
+6
+0.4% +$1.38K 0.11% 186
2024
Q3
$328K Buy
1,469
+126
+9% +$27.7K 0.11% 181
2024
Q2
$273K Hold
1,343
0.1% 187
2024
Q1
$270K Buy
1,343
+306
+30% +$67.4K 0.1% 187
2023
Q4
$236K Buy
+1,037
New +$218K 0.09% 197

Other funds holding LH

White Pine Capital's LH Position: Q1 2026 in Review

White Pine Capital reduced its Labcorp (LH) stake by 7.2% in Q1 2026, selling an estimated $30.1K and leaving 1,432 shares worth $382K. The position accounts for 0.11% of the portfolio, ranked #184.

White Pine Capital first reported a position in LH in Q4 2023 and has held it in 10 quarters since. The position peaked at $442K in Q3 2025. 1,031 funds tracked by Wall St. Rank hold LH as of Q1 2026.

  • White Pine Capital held 1,432 shares of Labcorp worth $382K as of Q1 2026.
  • White Pine Capital sold 111 Labcorp shares in Q1 2026, an estimated $30.1K.
  • Labcorp made up 0.11% of White Pine Capital's portfolio in Q1 2026, its #184 holding.
  • White Pine Capital first reported a position in Labcorp in Q4 2023 and has held it in 10 quarters since.
  • White Pine Capital's Labcorp position peaked at $442K in Q3 2025.
  • 1,031 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.

Based on White Pine Capital's 13F filing for Q1 2026, filed 11 May 2026.